Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Endovascular Thoracic Aneurysm Repair Deemed Safer Than Open Surgery

By HospiMedica International staff writers
Posted on 21 May 2009
Endovascular, noninvasive thoracic aortic aneurysm repair (TEVAR) is safer than open aneurysm repair (OAR) as it is associated with fewer cardiac, respiratory, and hemorrhagic complications, according to a new study.

Researchers at the University of Michigan Medical School (Ann Arbor, USA) reviewed data from a large, unselected sampling of the U.S. More...
National Inpatient Sample (NIS) database that represents the entire scope of unruptured thoracic aortic aneurysm repairs in the United States. The researchers examined complications, mortality, hospital stay, hospital charges, patient disposition, discharge status, and patient demographics. Data was collected on 267 patients who underwent TEVAR and 1,030 patients who underwent OAR; the average ages were 66 years for OAR patients and nearly 70 years for TEVAR.

The researchers found that patients who underwent TEVAR had a higher burden of cardiovascular comorbidities, and were more likely to suffer from hypertension, renal insufficiency, chronic obstructive pulmonary disease (COPD), cerebrovascular occlusive disease, and peripheral artery disease (PAD). The researchers also found that OAR had a higher overall complication rate (33% versus 20%). More TEVAR patients were discharged from the hospital within the first few days of their procedure, and a significant number of OAR patients were hospitalized for more than 10 days. The two approaches were equivalent in their rates of in-hospital mortality and iatrogenic cerebrovascular accident; however, hematoma development, postoperative infections, and cardiac, respiratory, and hemorrhagic complications were more likely to occur in OAR patients. The study was published in the May 2009 issue of the Journal of Vascular Surgery.

"Our NIS data does not report long term complications of TEVAR such as endoleak, stent migration, and stent fracture which are known to occur frequently after discharge,” said lead author Gilbert Upchurch, Jr., M.D., of the department of surgery. "However, studies of midterm follow-up for TEVAR show that the real concern for death lies in the immediate perioperative period before hospital discharge, suggesting that our mortality rate accurately captures the bulk of repair-related deaths.”

Thoracic aortic aneurysms (TAAs) are aneurysms, which involve the ascending aorta, aortic arch, and descending thoracic aorta. Fifty percent of patients who experience a rupture of a thoracic aortic aneurysm die before reaching the hospital; furthermore, surgical repair of a ruptured thoracic aneurysm carries 25-50% mortality as opposed to a mortality rate of 5-8% when such aneurysms are treated electively. The operation also is fraught with complications, including paralysis and renal failure.

Related Links:

University of Michigan Medical School




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.